Hemopexin and Cancer

Hemopexin is the plasma protein with the highest affinity for heme. Seminal studies have highlighted its role in different kinds of heme-associated disorders, but its implication in cancer has been neglected for a long time. Considering the emerging importance of heme in tumors, the present review p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorito, Veronica, Tolosano, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780269/
https://www.ncbi.nlm.nih.gov/pubmed/35055182
http://dx.doi.org/10.3390/ijms23020997
_version_ 1784637795693756416
author Fiorito, Veronica
Tolosano, Emanuela
author_facet Fiorito, Veronica
Tolosano, Emanuela
author_sort Fiorito, Veronica
collection PubMed
description Hemopexin is the plasma protein with the highest affinity for heme. Seminal studies have highlighted its role in different kinds of heme-associated disorders, but its implication in cancer has been neglected for a long time. Considering the emerging importance of heme in tumors, the present review proposes an update of the works investigating hemopexin involvement in cancer, with the attempt to stimulate further future studies on this topic.
format Online
Article
Text
id pubmed-8780269
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87802692022-01-22 Hemopexin and Cancer Fiorito, Veronica Tolosano, Emanuela Int J Mol Sci Commentary Hemopexin is the plasma protein with the highest affinity for heme. Seminal studies have highlighted its role in different kinds of heme-associated disorders, but its implication in cancer has been neglected for a long time. Considering the emerging importance of heme in tumors, the present review proposes an update of the works investigating hemopexin involvement in cancer, with the attempt to stimulate further future studies on this topic. MDPI 2022-01-17 /pmc/articles/PMC8780269/ /pubmed/35055182 http://dx.doi.org/10.3390/ijms23020997 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Fiorito, Veronica
Tolosano, Emanuela
Hemopexin and Cancer
title Hemopexin and Cancer
title_full Hemopexin and Cancer
title_fullStr Hemopexin and Cancer
title_full_unstemmed Hemopexin and Cancer
title_short Hemopexin and Cancer
title_sort hemopexin and cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780269/
https://www.ncbi.nlm.nih.gov/pubmed/35055182
http://dx.doi.org/10.3390/ijms23020997
work_keys_str_mv AT fioritoveronica hemopexinandcancer
AT tolosanoemanuela hemopexinandcancer

Ejemplares similares